Esophageal Self-expandable Metal Stent for Malignant Strictures: a Safety and Efficacy Study

Inclusion Criteria:

• Patients presenting with dysphagia due to a non-curable malignant obstruction of theesophagus or esophagogastric junction including extrinsic malignant compression andrecurrence in post-esophagectomy patients;

• Requiring treatment for dysphagia (Ogilvie score of 2-41);

• Life expectancy of less than 12 months;

• Written informed consent;

• Age ≥ 18 years.

Exclusion Criteria:

• Stenosis after laryngectomy;

• Distance between the upper edge of the stent less than 2 cm from the upperesophageal sphincter;

• Tumor length of more than 14 cm;

• Previous stent placement for the same condition;

• Coagulopathy (not corrected prior to stent placement);

• Patients with eosinophilic esophagitis or an esophageal motility disorder;

• Nickel titanium (Nitinol) allergy.